Insmed to Present at the Evercore ISI 3rd Annual HealthCONx Conference

Rhea-AI Summary

Insmed Incorporated (Nasdaq: INSM) announced its participation in the virtual Evercore ISI 3rd Annual HealthCONx Conference, scheduled for December 1, 2020, at 8:00 a.m. ET. This presentation aims to showcase the company's advancements in treating serious and rare diseases. The event will include a live webcast accessible through their investor relations page, with an archived version available for 30 days post-event. Insmed's mission focuses on transforming the lives of patients with chronic pulmonary diseases and other unmet medical needs.

BRIDGEWATER, N.J., Nov. 24, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the virtual Evercore ISI 3^rd Annual HealthCONx Conference on Tuesday, December 1, 2020 at 8:00 a.m. ET.

The fireside chat will be webcast live and can be accessed by visiting the investor relations section of the company's website at www.insmed.com. The webcast will be archived for a period of 30 days following the conclusion of the live event.

About Insmed

Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States and the European Union to treat a chronic, debilitating lung disease. The Company is also progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a growing footprint across Europe and in Japan. For more information, visit www.insmed.com.

Contact:

Investors:

Argot Partners
Laura Perry or Heather Savelle
(212) 600-1902 
Insmed@argotpartners.com   

Media:

Mandy Fahey
Senior Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com 

 

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/insmed-to-present-at-the-evercore-isi-3rd-annual-healthconx-conference-301178239.html

SOURCE Insmed Incorporated

FAQ

When will Insmed present at the Evercore ISI HealthCONx Conference?

Insmed will present at the Evercore ISI 3rd Annual HealthCONx Conference on December 1, 2020, at 8:00 a.m. ET.

How can I watch Insmed's presentation at the conference?

You can watch Insmed's presentation by visiting the investor relations section of their website for a live webcast.

What is the focus of Insmed's business?

Insmed focuses on developing therapies for serious and rare diseases, including treatments for chronic pulmonary diseases.

Where is Insmed headquartered?

Insmed is headquartered in Bridgewater, New Jersey.

What products does Insmed offer?

Insmed's first commercial product is a therapy approved for chronic, debilitating lung disease, with additional investigational therapies in development.